Homeopathic Drug Diphtherinum Recalled for Manufacturing Practice Deviations
Washington Homeopathic Products is recalling Diphtherinum homeopathic remedy (potencies 14C, 30C, 200C) distributed nationwide due to manufacturing practice deviations (cGMP violations). Affected lots: 20332, 20333.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard is a manufacturing process deviation (cGMP violation) rather than a specific health threat. Voluntary recall initiated by the manufacturer indicates lower immediate risk.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Diphtherinum, a prescription homeopathic remedy available in 14C, 30C, and 200C potencies as liquid pellets. The recall covers lots 20332 and 20333, which were distributed nationwide.
The recall was initiated due to deviations from Current Good Manufacturing Practice (cGMP) standards. This was a voluntary recall initiated by the manufacturer on May 13, 2022. The recall was terminated on May 25, 2023.
No illnesses or injuries have been reported in connection with this recall. Consumers and healthcare providers who have received this product should verify the lot numbers and contact their healthcare provider or the manufacturer with questions.
The recalled product
- Product
- Diphtherinum, Potency: 14C, 30C, 200C, Liquid Pellets, Rx only, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411,
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 20332
- 20333
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27